Why Attend
The Annual European Microbiome Congress has become a trusted learning and networking platform for leading academics, practicing clinicians, pharmaceutical and nutrition companies, biotech entrepreneurs and investors, government and regulatory bodies and industry leaders who require insight into the latest microbiome research, clinical trials and multi-disciplinary collaborations.
Series Highlights
Past Speakers
Rose Szabady
Dr. Jordana T. Bell
Jordana Bell is a Senior Lecturer at King's College London. She studies the genomic basis of complex human disease in human populations, focusing on intermediate phenotypes including variation in epigenetic and microbiome profiles. In the context of human microbiome research, Jordana has contributed towards characterising host genetic and environmental influences on the gut microbiome, and understanding how variation in the microbiome relates to metabolic health.
William Wade
Magali Cordaillat-Simmons
Dr. Magali Cordaillat-Simmons earned her Ph. D. in 2005 at the Université Paris V René Descartes, France, in Cardiovascular Pharmacology where she studied the impact of high sodium intake on cardiac, vascular, and renal alterations.
She then had the opportunity to work as a research Associate at the University of Virginia, VA, USA, under the guidance of Pr. Ariel Gomez in the pediatrics department where she studied the influence of epigenetics on renin expression.
Today, Dr. Cordaillat works as the Scientific and Regulatory Affairs Director at the Pharmabiotic Research Institute (PRI), located in Narbonne, France. The PRI is a non-profit industry group dedicated to supporting companies in the development of Live Biotherapeutic Products in Europe.
There she manages the progression of the association’s European regulatory strategy regarding the evolution of the pharmaceutical legislation, the association‘s regulatory activities, the interactions with national medicines agencies, the European Medicines Agency, the European Pharmacopoeia and the European Commission.
Jean de Gunzburg
Talk to me about… your research
I am the chief scientific officer at Da Volterra, a French biotechnology company, headquartered in Paris, France. Da Volterra is committed to the discovery and development of innovative approaches to prevent the deleterious consequences of antibiotic treatments on the intestinal microbiota, including the emergence and dissemination of antimicrobial resistance, as well as the occurrence of infections by opportunistic pathogens such as Clostridium difficile. Prior to that, I led an academic career as a cell biologist focusing on signal transduction and oncogenesis, ultimately leading a research laboratory at the Institut Curie in Paris.
Talk to me about…something people may not know about you
I was born in Canada, lived for most of my life in France, and am now based in the London. I am an avid off-piste skier, in the French and Swiss Alps. I particularly enjoy the slow hiking/skinning up the mountains which gives me time to appreciate the fabulous scenery, and to think in depth about new and arising matters, in particular in relation to my research.
Cheryl Zimberlin
Wendy Russell
Lars Engstrand
Christian Roghi
Sarah Hemmasi
Marcus Claesson
Elisabeth Bik
Sebastien Guery
Ariel Cohen
Dr. Ariel Cohen is Director of Business Development and Alliances at BiomX, a microbiome drug discovery company. Prior to his role in BiomX, Dr. Cohen co-founded two biotech companies: OnTimeBio (Diagnostics) and Ensof Biosystems (Target discovery) and managed development of three academic discoveries to drug development companies. Dr. Cohen held business development roles at Integra Holdings, Yissum (Hebrew University’s Tech Transfer Office), and Aurum Ventures MKI. Prior to that Dr. Cohen served as Senior Project Manager at Evogene (NYSE:EVGN) an agriculture biotechnology company. Dr. Cohen holds a Ph.D. in Systems Biology and an M.Sc. in Computational Biology from the Weizmann Institute of Science and has published in top peer-reviewed journals, including; Science, Nature and Cell.
Mel Greaves
Professor Jeroen Raes
Jeroen Raes is group leader of the Bioinformatics and (eco-)Systems Biology (BSB) research group at VIB in Brussels. He has an extensive track record in meta-omics and microbiome research. He is associate editor for ISME journal, Scientific Reports (Nature publishing group), SIGS and Genomics Insights and is reviewer and/or committee member for ANR/NWO/FWO/ERC proposals.The Raes lab combines large-scale, next-generation sequencing with novel computational approaches to investigate the functioning and variability of the healthy human microbiome at the systems level and studies its alteration in disease.
Paul Wilmes
Sue Llewellyn
Dr. Henrik Bjørn Nielsen
Dr Morten L. Isaksen
Marcus De Goffau
Adrien Nivoliez
Dr Andrew Page
Dr. Ruairi C. Robertson
Mike Frodsham
Dr Hue-Tran Hornig-Do
Shahram Lavasani
Thought Leadership Partner
Metabolon
Website: http://www.metabolon.com/
Metabolon, Inc. is the world’s leading health technology company advancing metabolomics for clinical and research uses. Its Precision Metabolomics™ is accelerating research and product development across the pharmaceutical, biotechnology, consumer products, and nutrition industries. The company was founded in 2000 and is based in Research Triangle Park, North Carolina.
Event Partners
Clinical Microbiomics
Website: http://www.clinical-microbiomics.com
Clinical Microbiomics is specialized in microbiome metagenomics and innovative bioinformatics concepts. We offer end-to-end microbiome research services for clinical and pre-clinical research including DNA-extraction, library preparation, sequencing and bioinformatics. Our proprietary bioinformatics platform provides our partners with leading capabilities to analyze and interpret microbiome metagenomics data.
With our pioneering Metagenomic Species Concept (MGS) and the most extensive collection of deep-sequenced human and mouse gut samples, we capture up to 80% of the microbiome diversity, which greatly supersedes normal reference-based methods. This provides our clients with a market-leading platform for studying the microbiome in relation to health, disease and treatment interventions. In addition, it allows for diverse applications, such as biomarker and drug target discovery, disease etiology investigation and subject stratification. With our range of advanced bioinformatics tools and experience in big data integration, we are able to move from association studies to mechanistic insights on microbiome metabolism and dynamics.
Cosmos ID
Website: http://www.cosmosid.com
CosmosID®, based in Rockville, Maryland, provides solutions unlocking the microbiome. A provider of Next-Generation Sequencing (NGS) Services and Bioinformatics Solutions, CosmosID focuses on microbiome analysis and the rapid identification and characterization of microorganisms for pharmaceutical R&D, molecular diagnostics, public health, food safety, agriculture, and environmental applications.
Services offered by CosmosID’s CLIA certified laboratory cover the entire workflow from study design to sample collection, extraction, library preparation, NGS, data analysis and publication support.
CosmosID’s cloud-based metagenomics application offers user-friendly access to the largest databases for microbial genomics, antimicrobial resistance (AMR) and virulence (VIR) data and has been independently validated to return metagenomic analyses at strain level resolution with industry leading sensitivity and precision.
Biose Industrie
Website: https://www.biose.com/en/cdmo/
Biose Industrie is a Contract Development and Manufacturing Organization (CDMO), specialised in Live Biotherapeutic Products. Founded in 1951, Biose Industrie has more than 65 years of experience in the development and production of live bacteria based drugs. Company offers lab development specialised in microbiology (anaerobic, aerobic, GMO strains) and is Drug GMP certified for the manufacturing of API (From 300L to 3 500L), clinical batches and commercial drug products (capsules in blisters or pills, sachets).
M2P Labs
Website: http://www.m2p-labs.com/
Based in Baesweiler, Germany (near Aachen), the company was founded in November 2005 as a spin-off of RWTH Aachen University. The company focuses on microreaction and automated solutions for screening and bioprocess development. Our commercialized products are the BioLector, the BioLector Pro, and the FlowerPlate, which provide an intelligent micro fermentation platform. This proprietary technology empowers the biotechnology, chemical, and pharmaceutical industries to increase the number and the information content of microbial experiments (aerobic, microaerophilic, and strictly anaerobic). It enables customers to conduct experiments with high efficiency and excellent quality in microscale at low costs. With the RoboLector, the company also enables the
automated fermentation of the whole bioprocess, with the specific integration of the BioLector tool into a liquid handling system.
Zymo Research
Website: http://www.zymoresearch.com
Zymo Research is historically recognized for its innovation of high quality nucleic acid purification technologies. Under the branding DNA Purification Made Simple™ and RNA Purification Made Simple™, our technologies are pushing the limits of what is possible with nucleic acid isolation. As The Epigenetics Company™, Zymo Research has also received much attention for its rapidly expanding portfolio of epigenetics products and services. It is our objective to develop and provide the most comprehensive set of tools for DNA, RNA, and epigenetic research and analysis available today. Thousands of peer-reviewed scientific publications from researchers around the world feature our technologies. Through innovation, our scientists have made streamlined DNA methylation detection possible, pioneered the micro-elution column for DNA and RNA purification, developed the simplest and the most sophisticated methods for high-quality plasmid DNA purification, and patented the first RNA purification directly from Trizol® without phase separation among many other leading technologies in the industry.
At Zymo Research, we are committed to quality and guarantee that all of our products and service will meet and exceed your expectations. Our products are constantly evaluated by scientists like you to help ensure their reliability and the highest standard of quality.
Become a Sponsor
Kisaco Research provides the much needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at partner@kisacoresearch.com.
The Agenda
We're hard at work creating the agenda for 2019, but in the meantime please take a look at the 2018 programme to find out more information about the Summit including the main topics of discussion that we covered in last year's brilliant two-day event.
Download Last Year's Agenda
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Poster Presentation Submission
If you are looking to highlight your recent work to the wider microbiome community, the dedicated poster session is a great way to get your research noticed and further involve yourself with the congress. In order to present a poster, you need to be registered as a delegate. Poster space is assigned on a first come, first served basis. Your presentation will be displayed in a dedicated poster area, while presentation sessions will take place both in the breaks and alongside sessions at prescheduled times.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.